MedTrace Logo

ONE PATH: Optimizing Nutrition Education for Parents and Teachers for Healthy Growth

NCT03817021 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1461

Last updated 2025-10-15

No results posted yet for this study

Summary

This proposal uses an innovative methodological framework, the multiphase optimization strategy (MOST), to design an effective and efficient responsive feeding (RF) intervention that promotes child appetite self-regulation among a high-risk sample: families with preschoolers living in rural poverty. The principles of MOST emphasize efficiency, allowing identification of the most efficacious intervention components (i.e., components that contribute to treatment effects) while minimizing participant burden and cost. ONE PATH will intervene on \~768 dyads recruited from 56 classrooms serving largely low-income, rural populations.

Conditions

  • Childhood Obesity
  • Self-regulation
  • Appetite Regulation

Interventions

BEHAVIORAL

ECE Provider

Provide online training for Head Start educators

BEHAVIORAL

Parent Intervention

Coach parents remotely to educate them on responsive feeding and parenting

BEHAVIORAL

Child intervention

Through classrooms lessons cover 3 topics: 1) self-regulation, 2) hunger and fullness, and 3) mindfulness in eating and attention control practices

Sponsors & Collaborators

  • Penn State University

    lead OTHER

Principal Investigators

  • Jennifer S Williams, PhD · Penn State University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
2 Years
Max Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-21
Primary Completion
2025-07-07
Completion
2025-07-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03817021 on ClinicalTrials.gov